The Bull

Tuesday 26

March, 2019 7:33 PM

Aussie anti-STI condom gets Japan approval

Aussie anti-STI condom gets Japan approval

A Melbourne drug company's special condom with a gel that kills sexually transmitted diseases has been approved for sale in Japan.

Share |

By AAP 02.01.2019 12:20 PM

A Melbourne pharmaceutical company says its condom that kills certain STIs will soon be sold in Japan, one of the world's largest condom markets.

Starpharma's VivaGel condom contains a lubricant gel proven in laboratory settings to kill HIV, the herpes virus and HPV, the human papillomavirus that causes cervical cancer.

Starpharma said on Wednesday the condom had received final regulatory approval in Japan and will be sold by there by leading Japanese condom manufacturer Okamoto Industries under a licensing agreement.

Okamoto executive Keiji Ikeda said that condoms with functional gels represent the next wave in innovation in Japan, following a previous focus on condom thinness.

Starpharma CEO Dr Jackie Fairley called the regulatory approval "a key commercial milestone" for the condom.

VivaGel condoms are also approved for sale in Australia and Canada, where they are sold as LifeStyles Dual Protect Condoms.

Just after noon Starpharma Holdings shares were trading down 8.5 cents, or 7.17 per cent, to $1.10.

Index: Points Change Percent


© Copyright All rights reserved.